Navigation Links
Precancerous Lesions Raise Cervical Cancer Risk
Date:10/26/2007

Study finding may lead to changes in recommendations for Pap tests

FRIDAY, Oct. 26 (HealthDay News) -- Women who have had advanced precancerous lesions of the cervix are still at risk for invasive cancers up to 25 years later, Swedish researchers report.

Currently, the American Cancer Society recommends that women who have had precancerous lesions called severe dysplasia/carcinoma in situ (CIS) continue getting Pap tests for 10 years after treatment. But, based on this study, these guidelines may need to be changed, said Debbie Saslow, the society's director of breast and gynecologic cancer, who was not involved with the research.

Saslow added, however, that even though these women continue to be at risk for developing cervical or vaginal cancer, the risk is low. "Women who have been treated for advanced precancer do need to remain vigilant," she said.

"This paper is going in my file for when we update our guidelines in the next two years," Saslow added. "We will see if we want to stick with 10 years or go to a much wider interval."

The study was led by Dr. Bjorn Strander, a senior consultant with the Department of Obstetrics and Gynecology at Sahlgren's Academy at the University of Gothenburg. The researchers collected data on 132,493 women who had a diagnosis of severe dysplasia/CIS between 1958 and 2002. The statistics came from the National Swedish Cancer Register.

The researchers found 881 women had developed cervical cancer, and 111 had developed vaginal cancer more than one year after the initial diagnosis. This was almost seven times higher than expected, the researchers said.

Women with a diagnosis of severe dysplasia/CIS were more than twice as likely to develop cancer compared with the general female population. The women were also twice as likely to develop invasive cervical cancer after diagnosis of CIS if that diagnosis was made between 1991 and 2000, compared with the same diagnosis made from 1958 to 1970. This increased risk might be due to changes in treatment over that period, particularly because fewer hysterectomies are being done as part of treatment for CIS, the study authors said.

Strander's team also found a particularly high risk for women over age 50, and this risk continued to increase with age. "The risk after treatment hardly decreases at all after treatment and is still sustained after more than 25 years," he said.

"While well-screened women after 50 to 60 years of age are very well protected from cervical cancer and have little, if any, further use of screening, this does not apply to women who have been treated for grade 3 CIS," Strander said. "They need, and should have, long-term follow-up, perhaps lifelong," he said.

The results are published in the Oct. 26 edition of the British Medical Journal.

More information

For more on cervical cancer, visit the American Cancer Society.



SOURCES: Bjorn Strander, M.D., senior consultant, Department of Obstetrics and Gynecology, Sahlgren's Academy, University of Gothenburg, Sweden; Debbie Saslow, Ph.D., director, breast and gynecologic cancer, American Cancer Society, Atlanta; Oct. 26, 2007, British Medical Journal


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Approach to Treating Precancerous Esophagus Condition
2. Precancerous Blood Donors Do Not Pass on the Disease
3. Identifying brain lesions with impaired consciousness
4. Leveling Lupus Lesions
5. The Link Between Migraine And Brain Lesions Questioned
6. Lesions in the eyes may forecast a stroke
7. Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People
8. Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People
9. Combination of Bronchoscopic Techniques is Very Effective for Lung Lesions
10. Obesity raises IVF miscarriage risk
11. Heavy Drinking Raises Risk of Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: ... back to the presidency and to America. “Tomorrow Trump Goes To Washington” is the ... as she can for this country. , Nancy attributes her patriotic nature to her ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Fred Rides a Train” allows ... that follows. , “Fred Rides a Train” is the creation of published author, ... since her teen years in Michigan. The "Fred, the Dog" series is her first ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the fifth annual Business Architecture Innovation Summit in Reston, VA on March 21-22, ... who will share a range of experiences from a cross-section of industries such ...
(Date:12/7/2016)... ... ... NuevaCare, a leading home care agency based in San Mateo but serving ... part of its ambitious website relaunch. As Bay Area clients scramble to find quality ... their city. The new site has several key city-specific pages to address this need. ...
(Date:12/6/2016)... ... December 06, 2016 , ... People ... can be seen on a type of MRI, according to a study appearing ... of the central nervous system characterized by tremors or trembling and stiffness in ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 With opioids commonly used for pain management for ... market that has led to nationwide fatalities. The synthetic ... stronger than heroin or morphine, resulting in likelihood of addiction, abuse ... , , ... clinical operations, Behavioral Health for HMC HealthWorks, explained the opioid drug ...
(Date:12/6/2016)... -- Blueprint Medicines Corporation (NASDAQ: BPMC ), a ... patients with genomically defined diseases, today announced that it ... in shares of its common stock. In addition, Blueprint ... to purchase up to an additional of $18,750,000 million ... the public offering. All shares of common stock will ...
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 ... focused on the development of Conditionally Active ... BioAtla and Beijing Sinobioway Group Company, Limited ... programs for development.  The specific program candidates ... In March 2015, BioAtla and Sinobioway entered ...
Breaking Medicine Technology: